Overview

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke

Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This study will be conducted to determine the clinical efficacy of TB006 in participants with acute ischemic stroke.
Phase:
Phase 2
Details
Lead Sponsor:
TrueBinding, Inc.